News

Thirteen more national marketing authorizations in Europe are expected in the coming months. Simultaneously to this ongoing European decentralized procedure, registrations are to take place in 33 countries

National Association of Chain Drug Stores (NACDS) President and CEO Steven C. Anderson, IOM, CAE, issued a statement about the U.S. House of Representatives Ways and Means Committee’s

The option exercise, part of the $45 million Ebola program grant announced in April when Inovio received an initial $21 million award, was contingent upon Inovio successfully leading

DTC Eligibility allows for a Company’s securities to be traded electronically between brokerage accounts in the U.S. M Pharmaceutical CEO Matthew Lehman said: "DTC Eligibility is a significant

Can-Fite has already secured the FDA’s Orphan Drug designation for CF102, which is a small orally bioavailable drug that binds with high affinity and selectivity to the A3

Under the deal, if the company meets Phase 3 trial design objectives, it can seek regulatory approval of both TG-1101 and TGR-1202 in combination. The company will release

Vivolux said vast amounts of defective proteins formed in tumor cells disrupt the functioning of proteasome. The new mechanism of action by VLX1570 has been indicated to inhibit

Entresto is indicated to lower the risk of cardiovascular mortality and morbidity in patients with heart failure with reduced ejection fraction (HfrEF). It improves the protective neurohormonal systems

Appreciating the importance of the U.S. biotechnology and pharmaceutical market, Selvita decided to come closer to its partners and clients and open a fully-owned US subsidiary, Selvita Inc.